Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Classement en actions #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Prix de l'action
$0.00023723
Dernière synchronisation: 2024-08-26
Capitalisation boursière
$1.41K
Changement (1 jour)
111.67%
Changement (1 an)
0.00%
Pays
FR
Échange Pharnext S.A. (ALPHA)

Catégorie

Historique des divisions d’actions pour Pharnext S.A. (ALPHA)
L’action Pharnext S.A. (symbole : ALPHA) a subi un total de 4 divisions.
La division la plus récente a eu lieu le Feb 15, 2024.
Une action ALPHA achetée avant le Nov 23, 2022 équivaudrait aujourd’hui à 4.0E-16 actions ALPHA.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
2024-02-15 1:10000 x0.0001 x4.0E-16
2023-09-18 1:5000 x0.0002 x4.0E-12
2023-05-10 1:10000 x0.0001 x2.0E-8
2022-11-23 1:5000 x0.0002 x0.0002
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR